POEMS Syndrome

This is a rare condition that affects many parts of the body. It causes nerve problems, enlarged organs, hormone issues, abnormal proteins, and skin changes. It's often linked to a type of cancer called myeloma.

Condition

What people with POEMS Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you had Stem Cell Transplant for POEMS Syndrome?

NameHow it went

About POEMS Syndrome

What It Is

POEMS syndrome is a rare disorder in which a small group of abnormal plasma cells (the antibody-producing cells of the bone marrow) drives damage in many parts of the body. The name is an acronym for five common features: polyneuropathy (damage to many nerves), organomegaly (an enlarged liver, spleen or lymph nodes), endocrinopathy (hormone problems), M protein (an abnormal antibody made by those plasma cells) and skin changes such as darkening, thickening or extra hair growth. Not everyone has all five, and several important features, including fluid buildup, swelling of the optic nerve at the back of the eye and patches of abnormally dense bone, are not in the name at all. Nerve damage is the defining feature and usually the most disabling one. It typically begins as numbness, tingling or weakness in the feet, then gradually climbs the legs and reaches the hands, affecting both feeling and strength. POEMS is related to multiple myeloma, a cancer of plasma cells, and shares some of its treatments, but it behaves differently: the abnormal cells are usually few, and the problems come mainly from their effects on nerves, hormones and blood vessels rather than from the cells crowding the bone marrow. Left untreated it is life-threatening, but with modern treatment most people live for many years. Older names include Crow-Fukase syndrome and Takatsuki syndrome.

Causes & Risk Factors

The cause of POEMS syndrome is not understood, and no specific trigger has been identified. What is known is that it stems from a clone of plasma cells, meaning many copies of one abnormal cell. The condition is closely tied to very high levels of vascular endothelial growth factor (VEGF), a signaling protein that makes blood vessels leaky and encourages new vessel growth. VEGF levels rise and fall with disease activity and probably help explain the swelling and fluid buildup, but treatments that block VEGF alone have given mixed results, so it is unlikely to be the whole story. Other inflammatory signals, such as interleukin-6, are often raised as well. POEMS most often begins in adults in their 50s and is about one and a half times more common in men than in women. It is very rare: a national survey in Japan found roughly 3 cases per million people, and large groups of patients have since been described in many countries.

How It's Diagnosed

POEMS syndrome is often missed or recognized late, because its parts can look like several unrelated problems. The most common mix-up is with chronic inflammatory demyelinating polyneuropathy (CIDP), an immune disorder of the nerves. Nerve damage that does not respond to CIDP treatment, or that comes with a high platelet count, an M protein, unexplained swelling or fluid, or swelling of the optic nerves, is a strong reason to test for POEMS. No single test makes the diagnosis. Instead, doctors use a set of criteria. A person must have polyneuropathy and a plasma cell disorder, plus at least one of three other major features: sclerotic bone lesions (areas of abnormally dense bone), Castleman disease (a lymph node disorder) or a raised VEGF level. At least one minor feature is also needed, such as an enlarged organ, fluid buildup, a hormone problem, characteristic skin changes, optic nerve swelling or a high platelet or red blood cell count. Because the amount of M protein is often small, blood and urine need a sensitive test called immunofixation to find it. Testing also usually includes a VEGF blood level, a bone marrow biopsy, CT or PET-CT scans to look for bone lesions, nerve conduction studies, hormone tests and an eye examination. Heart ultrasound and breathing tests are added when needed. Getting the label right changes treatment: if POEMS is mistaken for a harmless M protein (monoclonal gammopathy of undetermined significance, or MGUS), it goes untreated and keeps progressing, while standard myeloma treatment often includes drugs, such as bortezomib, that can worsen nerve damage. The same tests set a baseline for judging how well treatment works.

Treatment Options

Treatment is aimed at the abnormal plasma cells, and the approach depends on how far they have spread. When a person has one to three isolated bone lesions and no abnormal plasma cells in a bone marrow sample taken from the hip, radiation to the lesions is the usual first treatment, and it can be curative. Improvement after radiation is gradual, unfolding over months to as long as three years. When abnormal plasma cells are spread through the bone marrow or there are many lesions, treatment is systemic, meaning medicines that act throughout the body. The main options come from myeloma care. They include melphalan or cyclophosphamide (chemotherapy drugs called alkylators); lenalidomide, a drug that dampens VEGF and inflammatory signals, usually given with the steroid dexamethasone and a blood thinner such as aspirin because of the clot risk; and high-dose melphalan followed by an autologous stem cell transplant, in which a person's own previously collected blood stem cells are returned to rebuild the bone marrow. Transplant can work very well for people fit enough for it, but it is intensive and has its own complications. Steroids on their own can help only temporarily. Thalidomide and bortezomib also act on the plasma cells but can make neuropathy worse, so doctors weigh them carefully and often prefer other options first. Newer myeloma drugs such as daratumumab look promising in small reports. Because POEMS is rare, these choices rest on small trials and case series rather than large head-to-head studies. Supportive care is essential for function and comfort while the nerves recover. Ankle-foot braces improve walking and reduce falls, and physical therapy helps maintain strength and prevent stiff, shortened muscles. Medicines such as gabapentin, pregabalin or a tricyclic antidepressant can ease nerve pain. People with severe weakness that affects breathing may use a CPAP or BiPAP machine, which delivers air pressure through a mask, to improve oxygen levels. Screening for depression is part of good care.

What to Expect

POEMS syndrome is a long-term condition, but it usually responds to treatment, and survival has improved considerably. In large series, about 8 in 10 people are alive 10 years after diagnosis. Some people treated with radiation for an isolated lesion are cured. Others relapse, sometimes years later, and need further treatment. Recovery of the nerves is slow, and this is the part people most need to be prepared for. Swelling, fluid buildup, optic nerve swelling and skin changes tend to improve first. Improvement in numbness and weakness often is not noticeable until about six months after treatment ends, and the greatest recovery may take two to three years. That lag does not mean treatment has failed. Recognizing and treating the condition promptly gives the best outcomes, and braces, mobility aids and physical therapy support walking and daily tasks while the nerves recover. Follow-up continues for life. A specialist, usually a hematologist, typically reviews progress every three to six months, comparing nerve examinations, VEGF and M protein levels and other tests with the starting baseline. Doctors watch the trend in VEGF rather than any single value, because the level does not always match how the disease is behaving. Long-term follow-up also watches for second blood cancers, which account for some later deaths.

When to Seek Help

See a doctor if numbness, tingling or weakness in the feet and legs keeps spreading, especially alongside unexplained swelling, darkening skin, a high platelet count or an M protein found on a blood test. Someone already diagnosed with CIDP whose symptoms keep worsening despite treatment should ask whether testing for POEMS makes sense. After diagnosis, contact the care team promptly for new or rapidly increasing swelling of the legs or belly, or shortness of breath that builds gradually or keeps increasing, which can mean fluid is building up around the lungs, heart or abdomen. Gradually blurring or double vision also needs prompt review, since it can reflect optic nerve swelling. People with POEMS have a higher risk of blood clots in arteries and veins. Call 911 right away for sudden numbness or weakness of the face, arm or leg, especially on one side, sudden trouble speaking or understanding speech, or sudden trouble seeing, which can signal a stroke, and for sudden shortness of breath or chest pain, which can signal a clot in the lung. New pain and swelling in one leg can mean a clot in a deep vein and needs a call to the care team the same day.

Questions to Ask Your Doctor

  1. 1.Which test results point to POEMS rather than CIDP, MGUS or myeloma, and is my disease limited to a few bone lesions or spread through the marrow?
  2. 2.Is radiation, medication or a stem cell transplant the best fit for me, and what do you expect each to achieve?
  3. 3.How long should it take before my numbness and weakness start to improve, and how will we measure progress in the meantime?
  4. 4.Which supportive treatments, such as braces, physical therapy or nerve pain medicine, should I start now?
  5. 5.How often will I need follow-up tests, and which changes would suggest the disease is coming back?

Last reviewed • Oct 2026

Educational content, not medical advice.